Literature DB >> 22270871

Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.

C A Carrasco1, M García, M Goycoolea, J Cerda, J Bertherat, O Padilla, D Meza, N Wohllk, T Quiroga.   

Abstract

The purpose of this article is to evaluate the variability and reproducibility of late night salivary cortisol (LNSC) using electrochemiluminescence immunoassay (ECLIA) and compare the accuracy of one or two samples in diagnosis of Cushing's syndrome (CS). We prospectively included 64 healthy volunteers (HV), 35 patients with clinically suspected CS (S), and 26 patients with confirmed CS. Nine patients in the CS group had 24-h urinary free cortisol (UFC) less than two times the upper limit of normal (mild CS). UFC and two consecutive LNSC (LNSC1, LNSC2) were collected at home. All patients in the S group had normal UFC and low-dose dexamethasone suppression test. No differences were found between the HV and S groups in UFC, LNSC1, and LNSC2. Intra-individual variability between the two samples of LNSC was 22% in HV (1.6-91%), 32% in the S group (1.6-144%), and 51% (1.6-156%) in the CS group. Variability was higher in CS patients than those in the HV (P < 0.001) and S groups (P = 0.05). The AUC of LNSC1 was 0.945 (IC 95% 0.880-1.004); when considering the highest LNSC, the AUC was 0.980 (IC 95% 0.954-1.007) (P < 0.01). We found 23% of discordant LNSC in the S group and 11% in the CS group. Three patients with CS had only one elevated LNSC, all of them with mild CS. Our results suggest that LNSC is variable, and reproducibility is affected in both CS and S patients. We found significant improvements in the diagnostic accuracy of the LNSC measurement by obtaining two samples.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270871     DOI: 10.1007/s12020-012-9597-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

1.  Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.

Authors:  M Castro; P C Elias; A R Quidute; F P Halah; A C Moreira
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

2.  Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing's syndrome.

Authors:  Cinzia Carrozza; Salvatore Maria Corsello; Rosa Maria Paragliola; Francesca Ingraudo; Sara Palumbo; Pietro Locantore; Antonella Sferrazza; Alfredo Pontecorvi; Cecilia Zuppi
Journal:  Ann Clin Biochem       Date:  2010-04-20       Impact factor: 2.057

3.  Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test.

Authors:  Alexander Viardot; Peter Huber; Jardena J Puder; Henryk Zulewski; Ulrich Keller; Beat Müller
Journal:  J Clin Endocrinol Metab       Date:  2005-07-12       Impact factor: 5.958

Review 4.  Diagnosis and differential diagnosis of Cushing's syndrome.

Authors:  J W Findling; H Raff
Journal:  Endocrinol Metab Clin North Am       Date:  2001-09       Impact factor: 4.741

5.  Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.

Authors:  M Trilck; J Flitsch; D K Lüdecke; R Jung; S Petersenn
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-04       Impact factor: 2.949

6.  Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.

Authors:  Pietro Putignano; Paola Toja; Antonella Dubini; Francesca Pecori Giraldi; Salvatore Maria Corsello; Francesco Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

7.  Late-night salivary cortisol as a screening test for Cushing's syndrome.

Authors:  H Raff; J L Raff; J W Findling
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio; Martina De Martin; Letizia M Fatti; Massimo Scacchi; Francesco Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

9.  Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.

Authors:  Carmen A Carrasco; Joël Coste; Laurence Guignat; Lionel Groussin; Marie Annick Dugué; Stéphane Gaillard; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

10.  Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

Authors:  Marie-Laure Nunes; Stéphanie Vattaut; Jean-Benoît Corcuff; Alexandre Rault; Hugues Loiseau; Blandine Gatta; Nathalie Valli; Luc Letenneur; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

View more
  9 in total

1.  Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Authors:  Zhanna E Belaya; Alexander V Iljin; Galina A Melnichenko; Liudmila Y Rozhinskaya; Natalia V Dragunova; Larisa K Dzeranova; Svetlana A Butrova; Ekaterina A Troshina; Ivan I Dedov
Journal:  Endocrine       Date:  2012-03-25       Impact factor: 3.633

2.  Salivary cortisol and the diagnosis of Cushing's syndrome: a coming of age.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

3.  Practical evaluation of late-night salivary cortisol: a real-life approach.

Authors:  Zhanna E Belaya; Galina A Melnichenko
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 4.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

5.  Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.

Authors:  Suhail A R Doi; Justin Clark; Anthony W Russell
Journal:  Endocrine       Date:  2012-12-14       Impact factor: 3.633

Review 6.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

7.  The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.

Authors:  F Ceccato; G Marcelli; M Martino; C Concettoni; M Brugia; L Trementino; G Michetti; G Arnaldi
Journal:  J Endocrinol Invest       Date:  2018-07-09       Impact factor: 4.256

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

Review 9.  Variability in laboratory parameters used for management of Cushing's syndrome.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio
Journal:  Endocrine       Date:  2015-07-10       Impact factor: 3.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.